韩国快速FEV1下降与肺癌发病风险的前瞻性队列研究
该纵向观察研究利用韩国两项人群队列(2001-2019年每两年随访一次),纳入8549名40-69岁接受肺功能检查者,定义FEV1年下降>60 mL为快速下降。
要点
- FEV1年下降>60 mL定义为快速下降,本队列发生率为15.1%。
- 快速FEV1下降者肺癌风险增加(校正HR 2.34,95%CI 1.28-4.28)。
- FEV1下降速率可能作为肺癌风险生物标志物。
核心结论
- FEV1下降速率可能是肺癌发生的潜在生物标志物。
- 快速FEV1下降是肺癌发病的独立危险因素。
研究设计与样本
- 纵向观察性研究,基于韩国两项人群队列(2001-2019年每两年随访)。
- 纳入8549名40-69岁接受肺功能随访的受试者。
- 采用校正Cox回归模型分析,协变量包括年龄、性别、吸烟史、FEV1/FVC和白细胞计数。
主要发现
- 快速FEV1下降者占15.1%(1287/8549),新发肺癌48例(0.6%)。
- 年龄≥45岁、吸烟≥30包年、基线FEV1/FVC低、FEF25-75低、快速FEV1下降及白细胞计数升高者肺癌风险增加。
- 时间依赖净重分类改善显示,在常规评估中加入FEV1下降速率有助于识别肺癌风险(分类NRI 0.32,95%CI 0.00-0.64;连续NRI 0.83,95%CI 0.14-1.25)。
关键数值与推荐
- 快速FEV1下降定义为FEV1年下降>60 mL。
- 肺癌发病风险增加的因素包括年龄≥45岁、吸烟≥30包年、基线FEV1/FVC低、FEF25-75低、快速FEV1下降及白细胞计数升高。
临床怎么用
- 在肺癌风险筛查中可考虑纳入FEV1下降速率,尤其对快速下降者加强随访。
局限性
- 原文未明确说明局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Impaired lung function is associated with a higher risk of developing lung cancer. However, lung function is a dynamic variable and must be evaluated longitudinally. This study reports on the relationship between accelerated lung function decline and development of lung cancer. RESEARCH QUESTION: Is accelerated lung function decline associated with the development of lung cancer? STUDY DESIGN AND METHODS: A longitudinal, observational study was performed by using epidemiologic data from two population-based studies comprising subjects assessed biannually from 2001 to 2019 in South Korea. Eligible subjects were between 40 and 69 years of age and were followed up by using spirometry. Spirometry measurements were made at each follow-up. Patients with a decline in FEV1 > 60 mL per year were defined as rapid FEV1 decliners. The relationship between lung cancer and rapid FEV1 decline was evaluated by using adjusted Cox regression models with covariates, including age, sex, smoking history, FEV1/FVC, and WBC count. RESULTS: Among the 8,549 eligible subjects, 1,287 (15.1%) had rapid FEV1 decline, and 48 (0.6%) had newly developed lung cancer. The risk of lung cancer development was increased in the subjects aged ≥ 45 years and those with ≥ 30 pack-years of smoking, low baseline FEV1/FVC, low forced expiratory flow between 25% and 75% of vital capacity, rapid FEV1 decline, and increased WBC count. Rapid FEV1 decline was an independent risk factor for lung cancer development (adjusted hazard ratio, 2.34; 95% CI, 1.28-4.28; P = .006). Time-dependent net reclassification improvement showed a benefit of FEV1 decline rate in determining subjects at risk of lung cancer when added to conventional practice (categorical, 0.32 [95% CI, 0.00-0.64]; continuous, 0.83 [95% CI, 0.14-1.25]). INTERPRETATION: The FEV1 decline rate may be a potential biomarker for lung cancer development. Further study is needed to identify whether patients with rapid FEV1 decline warrant lung cancer assessment or screening.
引用
- Lee HW, Lee HJ, Lee JK, et al. Rapid FEV1 Decline and Lung Cancer Incidence in South Korea. Chest. 2022. PMID: 35318007. doi:10.1016/j.chest.2022.03.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。